FAKTOR-OPTIONSSCHEIN - HALEON Stock

Certificat

DE000MG0J117

Market Closed - Börse Stuttgart 09:49:54 2024-05-24 EDT
10.67 EUR -4.56% Intraday chart for FAKTOR-OPTIONSSCHEIN - HALEON
Current month-12.68%
1 month-2.65%
Date Price Change
24-05-24 10.67 -4.56%
24-05-23 11.18 +1.82%
24-05-22 10.98 -2.83%
24-05-21 11.3 -1.22%
24-05-20 11.44 +2.42%

Delayed Quote Börse Stuttgart

Last update May 24, 2024 at 09:49 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MG0J11
ISINDE000MG0J117
Date issued 2024-03-20
Strike 219.3 p
Maturity Unlimited
Parity 0.12 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 12.22
Lowest since issue 10.47
Spread 0.04
Spread %0.38%

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.23 GBP
Average target price
3.62 GBP
Spread / Average Target
+12.07%
Consensus